1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug-Coated Device
        1.2.3 Prefilled Drug Delivery Systems
        1.2.4 Nebulizer and Inhaler
        1.2.5 Transdermal Delivery System
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Drug-Device Combination Products Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital andClinic
        1.3.3 Retail Pharmacies
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Drug-Device Combination Products Market Perspective (2017-2028)
    2.2 Drug-Device Combination Products Growth Trends by Region
        2.2.1 Drug-Device Combination Products Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Drug-Device Combination Products Historic Market Size by Region (2017-2022)
        2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2023-2028)
    2.3 Drug-Device Combination Products Market Dynamics
        2.3.1 Drug-Device Combination Products Industry Trends
        2.3.2 Drug-Device Combination Products Market Drivers
        2.3.3 Drug-Device Combination Products Market Challenges
        2.3.4 Drug-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Drug-Device Combination Products Players by Revenue
        3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2017-2022)
        3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2017-2022)
    3.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drug-Device Combination Products Revenue
    3.4 Global Drug-Device Combination Products Market Concentration Ratio
        3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2021
    3.5 Drug-Device Combination Products Key Players Head office and Area Served
    3.6 Key Players Drug-Device Combination Products Product Solution and Service
    3.7 Date of Enter into Drug-Device Combination Products Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Drug-Device Combination Products Breakdown Data by Type
    4.1 Global Drug-Device Combination Products Historic Market Size by Type (2017-2022)
    4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2023-2028)
5 Drug-Device Combination Products Breakdown Data by Application
    5.1 Global Drug-Device Combination Products Historic Market Size by Application (2017-2022)
    5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Drug-Device Combination Products Market Size (2017-2028)
    6.2 North America Drug-Device Combination Products Market Size by Country (2017-2022)
    6.3 North America Drug-Device Combination Products Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Drug-Device Combination Products Market Size (2017-2028)
    7.2 Europe Drug-Device Combination Products Market Size by Country (2017-2022)
    7.3 Europe Drug-Device Combination Products Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Drug-Device Combination Products Market Size (2017-2028)
    8.2 Asia-Pacific Drug-Device Combination Products Market Size by Country (2017-2022)
    8.3 Asia-Pacific Drug-Device Combination Products Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Drug-Device Combination Products Market Size (2017-2028)
    9.2 Latin America Drug-Device Combination Products Market Size by Country (2017-2022)
    9.3 Latin America Drug-Device Combination Products Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Drug-Device Combination Products Market Size (2017-2028)
    10.2 Middle East & Africa Drug-Device Combination Products Market Size by Country (2017-2022)
    10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Detail
        11.1.2 GSK Business Overview
        11.1.3 GSK Drug-Device Combination Products Introduction
        11.1.4 GSK Revenue in Drug-Device Combination Products Business (2017-2022)
        11.1.5 GSK Recent Development
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Company Detail
        11.2.2 Novo Nordisk Business Overview
        11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
        11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022)
        11.2.5 Novo Nordisk Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Drug-Device Combination Products Introduction
        11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 AstraZeneca
        11.4.1 AstraZeneca Company Detail
        11.4.2 AstraZeneca Business Overview
        11.4.3 AstraZeneca Drug-Device Combination Products Introduction
        11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022)
        11.4.5 AstraZeneca Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Detail
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Drug-Device Combination Products Introduction
        11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2017-2022)
        11.5.5 Sanofi Recent Development
    11.6 Boston Scientific
        11.6.1 Boston Scientific Company Detail
        11.6.2 Boston Scientific Business Overview
        11.6.3 Boston Scientific Drug-Device Combination Products Introduction
        11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022)
        11.6.5 Boston Scientific Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Detail
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Drug-Device Combination Products Introduction
        11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2017-2022)
        11.7.5 Abbott Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Detail
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
        11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Medtronic
        11.9.1 Medtronic Company Detail
        11.9.2 Medtronic Business Overview
        11.9.3 Medtronic Drug-Device Combination Products Introduction
        11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2017-2022)
        11.9.5 Medtronic Recent Development
    11.10 Mylan
        11.10.1 Mylan Company Detail
        11.10.2 Mylan Business Overview
        11.10.3 Mylan Drug-Device Combination Products Introduction
        11.10.4 Mylan Revenue in Drug-Device Combination Products Business (2017-2022)
        11.10.5 Mylan Recent Development
    11.11 3M
        11.11.1 3M Company Detail
        11.11.2 3M Business Overview
        11.11.3 3M Drug-Device Combination Products Introduction
        11.11.4 3M Revenue in Drug-Device Combination Products Business (2017-2022)
        11.11.5 3M Recent Development
    11.12 Hisamitsu
        11.12.1 Hisamitsu Company Detail
        11.12.2 Hisamitsu Business Overview
        11.12.3 Hisamitsu Drug-Device Combination Products Introduction
        11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022)
        11.12.5 Hisamitsu Recent Development
    11.13 Smith & Nephew
        11.13.1 Smith & Nephew Company Detail
        11.13.2 Smith & Nephew Business Overview
        11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
        11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022)
        11.13.5 Smith & Nephew Recent Development
    11.14 Molnlycke
        11.14.1 Molnlycke Company Detail
        11.14.2 Molnlycke Business Overview
        11.14.3 Molnlycke Drug-Device Combination Products Introduction
        11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022)
        11.14.5 Molnlycke Recent Development
    11.15 Teleflex
        11.15.1 Teleflex Company Detail
        11.15.2 Teleflex Business Overview
        11.15.3 Teleflex Drug-Device Combination Products Introduction
        11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2017-2022)
        11.15.5 Teleflex Recent Development
    11.16 BD
        11.16.1 BD Company Detail
        11.16.2 BD Business Overview
        11.16.3 BD Drug-Device Combination Products Introduction
        11.16.4 BD Revenue in Drug-Device Combination Products Business (2017-2022)
        11.16.5 BD Recent Development
    11.17 Lepu Medical
        11.17.1 Lepu Medical Company Detail
        11.17.2 Lepu Medical Business Overview
        11.17.3 Lepu Medical Drug-Device Combination Products Introduction
        11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022)
        11.17.5 Lepu Medical Recent Development
    11.18 MicroPort
        11.18.1 MicroPort Company Detail
        11.18.2 MicroPort Business Overview
        11.18.3 MicroPort Drug-Device Combination Products Introduction
        11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2017-2022)
        11.18.5 MicroPort Recent Development
    11.19 Terumo
        11.19.1 Terumo Company Detail
        11.19.2 Terumo Business Overview
        11.19.3 Terumo Drug-Device Combination Products Introduction
        11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2017-2022)
        11.19.5 Terumo Recent Development
    11.20 B. Braun
        11.20.1 B. Braun Company Detail
        11.20.2 B. Braun Business Overview
        11.20.3 B. Braun Drug-Device Combination Products Introduction
        11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2017-2022)
        11.20.5 B. Braun Recent Development
    11.21 Antares Pharma
        11.21.1 Antares Pharma Company Detail
        11.21.2 Antares Pharma Business Overview
        11.21.3 Antares Pharma Drug-Device Combination Products Introduction
        11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022)
        11.21.5 Antares Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug-Coated Device
    Table 3. Key Players of Prefilled Drug Delivery Systems
    Table 4. Key Players of Nebulizer and Inhaler
    Table 5. Key Players of Transdermal Delivery System
    Table 6. Key Players of Others
    Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Drug-Device Combination Products Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Drug-Device Combination Products Market Share by Region (2017-2022)
    Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Drug-Device Combination Products Market Share by Region (2023-2028)
    Table 13. Drug-Device Combination Products Market Trends
    Table 14. Drug-Device Combination Products Market Drivers
    Table 15. Drug-Device Combination Products Market Challenges
    Table 16. Drug-Device Combination Products Market Restraints
    Table 17. Global Drug-Device Combination Products Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Drug-Device Combination Products Market Share by Players (2017-2022)
    Table 19. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2021)
    Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drug-Device Combination Products Product Solution and Service
    Table 24. Date of Enter into Drug-Device Combination Products Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug-Device Combination Products Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2017-2022)
    Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2023-2028)
    Table 30. Global Drug-Device Combination Products Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2017-2022)
    Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2023-2028)
    Table 34. North America Drug-Device Combination Products Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Drug-Device Combination Products Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Drug-Device Combination Products Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Drug-Device Combination Products Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Drug-Device Combination Products Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Drug-Device Combination Products Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Drug-Device Combination Products Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Drug-Device Combination Products Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Drug-Device Combination Products Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Country (2023-2028) & (US$ Million)
    Table 44. GSK Company Detail
    Table 45. GSK Business Overview
    Table 46. GSK Drug-Device Combination Products Product
    Table 47. GSK Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 48. GSK Recent Development
    Table 49. Novo Nordisk Company Detail
    Table 50. Novo Nordisk Business Overview
    Table 51. Novo Nordisk Drug-Device Combination Products Product
    Table 52. Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 53. Novo Nordisk Recent Development
    Table 54. Eli Lilly Company Detail
    Table 55. Eli Lilly Business Overview
    Table 56. Eli Lilly Drug-Device Combination Products Product
    Table 57. Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 58. Eli Lilly Recent Development
    Table 59. AstraZeneca Company Detail
    Table 60. AstraZeneca Business Overview
    Table 61. AstraZeneca Drug-Device Combination Products Product
    Table 62. AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 63. AstraZeneca Recent Development
    Table 64. Sanofi Company Detail
    Table 65. Sanofi Business Overview
    Table 66. Sanofi Drug-Device Combination Products Product
    Table 67. Sanofi Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 68. Sanofi Recent Development
    Table 69. Boston Scientific Company Detail
    Table 70. Boston Scientific Business Overview
    Table 71. Boston Scientific Drug-Device Combination Products Product
    Table 72. Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 73. Boston Scientific Recent Development
    Table 74. Abbott Company Detail
    Table 75. Abbott Business Overview
    Table 76. Abbott Drug-Device Combination Products Product
    Table 77. Abbott Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 78. Abbott Recent Development
    Table 79. Boehringer Ingelheim Company Detail
    Table 80. Boehringer Ingelheim Business Overview
    Table 81. Boehringer Ingelheim Drug-Device Combination Products Product
    Table 82. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 83. Boehringer Ingelheim Recent Development
    Table 84. Medtronic Company Detail
    Table 85. Medtronic Business Overview
    Table 86. Medtronic Drug-Device Combination Products Product
    Table 87. Medtronic Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 88. Medtronic Recent Development
    Table 89. Mylan Company Detail
    Table 90. Mylan Business Overview
    Table 91. Mylan Drug-Device Combination Products Product
    Table 92. Mylan Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 93. Mylan Recent Development
    Table 94. 3M Company Detail
    Table 95. 3M Business Overview
    Table 96. 3M Drug-Device Combination ProductsProduct
    Table 97. 3M Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 98. 3M Recent Development
    Table 99. Hisamitsu Company Detail
    Table 100. Hisamitsu Business Overview
    Table 101. Hisamitsu Drug-Device Combination ProductsProduct
    Table 102. Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 103. Hisamitsu Recent Development
    Table 104. Smith & Nephew Company Detail
    Table 105. Smith & Nephew Business Overview
    Table 106. Smith & Nephew Drug-Device Combination ProductsProduct
    Table 107. Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 108. Smith & Nephew Recent Development
    Table 109. Molnlycke Company Detail
    Table 110. Molnlycke Business Overview
    Table 111. Molnlycke Drug-Device Combination ProductsProduct
    Table 112. Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 113. Molnlycke Recent Development
    Table 114. Teleflex Company Detail
    Table 115. Teleflex Business Overview
    Table 116. Teleflex Drug-Device Combination ProductsProduct
    Table 117. Teleflex Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 118. Teleflex Recent Development
    Table 119. BD Company Detail
    Table 120. BD Business Overview
    Table 121. BD Drug-Device Combination ProductsProduct
    Table 122. BD Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 123. BD Recent Development
    Table 124. Lepu Medical Company Detail
    Table 125. Lepu Medical Business Overview
    Table 126. Lepu Medical Drug-Device Combination ProductsProduct
    Table 127. Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 128. Lepu Medical Recent Development
    Table 129. MicroPort Company Detail
    Table 130. MicroPort Business Overview
    Table 131. MicroPort Drug-Device Combination ProductsProduct
    Table 132. MicroPort Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 133. MicroPort Recent Development
    Table 134. Terumo Company Detail
    Table 135. Terumo Business Overview
    Table 136. Terumo Drug-Device Combination ProductsProduct
    Table 137. Terumo Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 138. Terumo Recent Development
    Table 139. B. Braun Company Detail
    Table 140. B. Braun Business Overview
    Table 141. B. Braun Drug-Device Combination ProductsProduct
    Table 142. B. Braun Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 143. B. Braun Recent Development
    Table 144. Antares Pharma Company Detail
    Table 145. Antares Pharma Business Overview
    Table 146. Antares Pharma Drug-Device Combination ProductsProduct
    Table 147. Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
    Table 148. Antares Pharma Recent Development
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug-Device Combination Products Market Share by Type: 2021 VS 2028
    Figure 2. Drug-Coated Device Features
    Figure 3. Prefilled Drug Delivery Systems Features
    Figure 4. Nebulizer and Inhaler Features
    Figure 5. Transdermal Delivery System Features
    Figure 6. Others Features
    Figure 7. Global Drug-Device Combination Products Market Share by Application in 2021 & 2028
    Figure 8. Hospital andClinic Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Other Case Studies
    Figure 11. Drug-Device Combination Products Report Years Considered
    Figure 12. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Drug-Device Combination Products Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Drug-Device Combination Products Market Share by Region: 2021 VS 2028
    Figure 15. Global Drug-Device Combination Products Market Share by Players in 2021
    Figure 16. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2021
    Figure 18. North America Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Drug-Device Combination Products Market Share by Country (2017-2028)
    Figure 20. United States Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Drug-Device Combination Products Market Share by Country (2017-2028)
    Figure 24. Germany Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Drug-Device Combination Products Market Share by Region (2017-2028)
    Figure 32. China Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Drug-Device Combination Products Market Share by Country (2017-2028)
    Figure 40. Mexico Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Drug-Device Combination Products Market Share by Country (2017-2028)
    Figure 44. Turkey Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 47. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 48. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 50. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 51. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 52. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 53. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 54. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 55. Mylan Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 56. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 57. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 58. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 59. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 60. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 61. BD Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 62. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 63. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 64. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 65. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 66. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed